Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesSS-31 (Elamipretide): Latest Evidence and 2026
Explore the cutting-edge science behind SS-31 (Elamipretide), with a focus on breakthroughs from 2025-2026 and its potential in healthy ageing.
PeptidesPinealon: Cognitive Resilience Updates &
Dive into the latest 2025-2026 clinical research on Pinealon, focusing on its role in cognitive resilience and updated recommendations for brain health.
PeptidesSS-31 (Elamipretide) in 2026: Unpacking the
SS-31 (Elamipretide) continues to garner attention for its mitochondrial-targeting properties. We delve into the newest clinical data and revised insights for 2026.
PeptidesCJC-1295: Latest Clinical Evidence & Safety
Dive into the latest 2026 clinical evidence for CJC-1295 with DAC, examining its mechanisms, revised benefits, and safety considerations for healthspan optimisation.
PeptidesSS-31 (Elamipretide) Latest Evidence 2026: A
This updated review focuses on the latest 2025-2026 evidence for SS-31 (Elamipretide), dissecting new clinical trials and their implications for longevity and mitochondrial health.
PeptidesDihexa: Latest 2026 Evidence and Cognitive
Dihexa, a potent hexapeptide, continues to intrigue researchers. This article examines the latest 2026 evidence surrounding its cognitive enhancement potential and safety profile.
PeptidesTB-500: Latest 2026 Evidence and Clinical
Exploring the cutting-edge 2026 evidence for TB-500, a synthetic peptide lauded for tissue regeneration, and assessing its evolving role in healthspan.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.